Triple negative breast cancer-BCL2 in prognosis and prediction. Review
Triple negative breast cancer-BCL2 in prognosis and prediction. Review.
Current Drug Targets.
2014,
15(12),
1166-1175,
ISSN: 1389-4501,
PMID: 25374001,